Literature DB >> 11145997

A novel transverse push-pull microprobe: in vitro characterization and in vivo demonstration of the enzymatic production of adenosine in the spinal cord dorsal horn.

S L Patterson1, K A Sluka, M A Arnold.   

Abstract

Adenosine produces analgesia in the spinal cord and can be formed extracellularly through enzymatic conversion of adenine nucleotides. A transverse push-pull microprobe was developed and characterized to sample extracellular adenosine concentrations of the dorsal horn of the rat spinal cord. Samples collected via this sampling technique reveal that AMP is converted to adenosine in the dorsal horn. This conversion is decreased by the ecto-5'-nucleotidase inhibitor, alpha,beta-methylene ADP. Related behavioral studies demonstrate that AMP administered directly to the spinal cord can reverse the secondary mechanical hyperalgesia characteristic of the intradermal capsaicin model of inflammatory pain. The specific adenosine A(1) receptor antagonist 8-cyclopentyl-1,3-dimethylxanthine (CPT) inhibits the antihyperalgesia produced by AMP. This research introduces a novel microprobe that can be used as an adjunct sampling technique to microdialysis and push-pull cannulas. Furthermore, we conclude that AMP is converted to adenosine in the dorsal horn of the spinal cord by ecto-5'-nucleotidase and subsequently may be one source of adenosine, acting through adenosine A(1) receptors in the dorsal horn of the spinal cord, which produce antihyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145997     DOI: 10.1046/j.1471-4159.2001.00016.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Increased release of serotonin in the spinal cord during low, but not high, frequency transcutaneous electric nerve stimulation in rats with joint inflammation.

Authors:  Kathleen A Sluka; Tammy L Lisi; Karin N Westlund
Journal:  Arch Phys Med Rehabil       Date:  2006-08       Impact factor: 3.966

2.  Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain.

Authors:  P W Wacnik; L J Eikmeier; T R Ruggles; M L Ramnaraine; B K Walcheck; A J Beitz; G L Wilcox
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

3.  AMP is an adenosine A1 receptor agonist.

Authors:  Joseph E Rittiner; Ilia Korboukh; Emily A Hull-Ryde; Jian Jin; William P Janzen; Stephen V Frye; Mark J Zylka
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

4.  Receptor activated bladder and spinal ATP release in neurally intact and chronic spinal cord injured rats.

Authors:  Nilson A Salas; George T Somogyi; David A Gangitano; Timothy B Boone; Christopher P Smith
Journal:  Neurochem Int       Date:  2006-10-25       Impact factor: 3.921

Review 5.  Pain-relieving prospects for adenosine receptors and ectonucleotidases.

Authors:  Mark J Zylka
Journal:  Trends Mol Med       Date:  2011-01-13       Impact factor: 11.951

6.  Ecto-5'-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits.

Authors:  Nathaniel A Sowa; Bonnie Taylor-Blake; Mark J Zylka
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

7.  IL-10 cytokine released from M2 macrophages is crucial for analgesic and anti-inflammatory effects of acupuncture in a model of inflammatory muscle pain.

Authors:  Morgana D da Silva; Franciane Bobinski; Karina L Sato; Sandra J Kolker; Kathleen A Sluka; Adair R S Santos
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

8.  Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease.

Authors:  Zeyun Mi; Yandong Song; Xinyi Cao; Yi Lu; Zhiheng Liu; Xu Zhu; Meijuan Geng; Yongzhan Sun; Bingxue Lan; Chaoran He; Hui Xiong; Lirong Zhang; Yupeng Chen
Journal:  Nat Metab       Date:  2020-07-13

9.  Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine.

Authors:  Mark J Zylka; Nathaniel A Sowa; Bonnie Taylor-Blake; Margaret A Twomey; Annakaisa Herrala; Vootele Voikar; Pirkko Vihko
Journal:  Neuron       Date:  2008-10-09       Impact factor: 17.173

10.  PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine.

Authors:  Sarah E Street; Paul L Walsh; Nathaniel A Sowa; Bonnie Taylor-Blake; Thomas S Guillot; Pirkko Vihko; R Mark Wightman; Mark J Zylka
Journal:  Mol Pain       Date:  2011-10-19       Impact factor: 3.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.